Tildrakizumab Gets EMA Panel Nod for Plaque Psoriasis Tildrakizumab Gets EMA Panel Nod for Plaque Psoriasis

A European Medicines Agency panel has recommended tildrakizumab for the treatment of moderate to severe plaque psoriasis.International Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology News Alert Source Type: news